AstraZeneca completes sale of Zeneca specialities

ASTRAZENECA COMPLETES SALE OF ZENECA SPECIALITIES

AstraZeneca today completed the previously announced sale of its Zeneca
Specialities business for a cash amount of $2.1 billion (£1.3) in a buyout
jointly financed by Cinven and Investcorp.

Further enquiries:

Media:
Steve Brown, Media Relations Manager, tel +44 171 304 5033
Social Media Pitch:
AstraZeneca completes sale of Zeneca specialities